Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 3,489 shares at $29.12 ($102K) on 2026-01-14, disclosed to the SEC on 2026-01-16.
Open-market sale of $102k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |
| OLMA | SELL | 2024-12-11 | $294K | — | Filing → |